IN8BIO, INC. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD for Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
In8 Bio, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate for Q4 2023.
  • In8 Bio, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $2.7M.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.7M Dec 31, 2023 10-K 2024-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.